Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cemiplimab for Locally Advanced and Metastatic Cutaneous Squamous-Cell Carcinomas: Real-Life Experience from the French CAREPI Study Group.
Hober C, Fredeau L, Pham-Ledard A, Boubaya M, Herms F, Celerier P, Aubin F, Beneton N, Dinulescu M, Jannic A, Meyer N, Duval-Modeste AB, Cesaire L, Neidhardt ÈM, Archier É, Dréno B, Lesage C, Berthin C, Kramkimel N, Grange F, de Quatrebarbes J, Stoebner PE, Poulalhon N, Arnault JP, Abed S, Bonniaud B, Darras S, Heidelberger V, Devaux S, Moncourier M, Misery L, Mansard S, Etienne M, Brunet-Possenti F, Jacobzone C, Lesbazeilles R, Skowron F, Sanchez J, Catala S, Samimi M, Tazi Y, Spaeth D, Gaudy-Marqueste C, Collard O, Triller R, Pracht M, Dumas M, Peuvrel L, Combe P, Lauche O, Guillet P, Reguerre Y, Kupfer-Bessaguet I, Solub D, Schoeffler A, Bedane C, Quéreux G, Dalac S, Mortier L, Maubec È. Hober C, et al. Among authors: moncourier m. Cancers (Basel). 2021 Jul 15;13(14):3547. doi: 10.3390/cancers13143547. Cancers (Basel). 2021. PMID: 34298764 Free PMC article.
Duration of treatment with cemiplimab in advanced cutaneous squamous cell carcinoma in complete response: Real-life study.
Khelef K, Maubec E, Jeudy G, Bonniaud B, Pham-Ledard A, Herms F, Aubin F, Beneton N, Dinulescu M, Jannic A, Duval-Modeste A, Archier E, Berthin C, Grange F, Arnault J, Heidelberger V, Moncourier M, Mansard S, Brunet-Possenti F, Triller R, Pracht M, Dumas M, Lauche O, Mortier L, Bedane C, Dalac Rat S. Khelef K, et al. Among authors: moncourier m. J Eur Acad Dermatol Venereol. 2024 Jan;38(1):e71-e73. doi: 10.1111/jdv.19435. Epub 2023 Sep 23. J Eur Acad Dermatol Venereol. 2024. PMID: 37595320 No abstract available.
Visible light-induced solar urticaria is improved by omalizumab.
Moncourier M, Assikar S, Matei I, Souyri N, Couture M, Rigot E, Delauménie S, Bédane C. Moncourier M, et al. Photodermatol Photoimmunol Photomed. 2016 Sep;32(5-6):314-316. doi: 10.1111/phpp.12271. Epub 2016 Sep 29. Photodermatol Photoimmunol Photomed. 2016. PMID: 27622987 No abstract available.
Major response to pembrolizumab in two patients with locally advanced cutaneous squamous cell carcinoma.
Degache E, Crochet J, Simon N, Tardieu M, Trabelsi S, Moncourier M, Templier I, Foroni L, Lemoigne A, Pinel N, Gil H, Bouillet L, Leccia MT, Charles J. Degache E, et al. Among authors: moncourier m. J Eur Acad Dermatol Venereol. 2018 Jul;32(7):e257-e258. doi: 10.1111/jdv.14371. Epub 2017 Jul 19. J Eur Acad Dermatol Venereol. 2018. PMID: 28557105 No abstract available.
[Granulomatous periocular eruption].
Moncourier M, Pralong P, Pinel N, Templier I, Leccia MT. Moncourier M, et al. Ann Dermatol Venereol. 2017 Jun-Jul;144(6-7):430-433. doi: 10.1016/j.annder.2017.03.018. Epub 2017 Apr 12. Ann Dermatol Venereol. 2017. PMID: 28410769 French.